Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration
Jacob T. Jackson, Elisabeth Mulazzani, Stephen L. Nutt, et al.
Journal of Biological Chemistry (2021) Vol. 297, Iss. 2, pp. 100905-100905
Open Access | Times Cited: 75

Showing 26-50 of 75 citing articles:

PLCG2 and IFNAR1: The Potential Biomarkers Mediated by Immune Infiltration and Osteoclast Differentiation of Ankylosing Spondylitis in the Peripheral Blood
Bo Han, Qiaobo Xie, Weishi Liang, et al.
Mediators of Inflammation (2024) Vol. 2024, pp. 1-14
Open Access | Times Cited: 2
Alzheimer’s disease-associated protective variant Plcg2-P522R modulates peripheral macrophage function in a sex-dimorphic manner
Hannah A. Staley, Janna Jernigan, MacKenzie L. Bolen, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Regional genetic correlations highlight relationships between neurodegenerative disease loci and the immune system
Frida Lona‐Durazo, Regina H. Reynolds, Sonja W. Scholz, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 6
Clinical and immunological features of an APLAID patient caused by a novel mutation in PLCG2
Peng Qi, Dong Luo, Yi Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Canonical Inflammasomes
Vinícius Nunes Cordeiro Leal, Alessandra Pontillo
Methods in molecular biology (2023), pp. 1-27
Closed Access | Times Cited: 4
Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors
Emanuela Minna, Andrea Devecchi, Federico Pistore, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
A novel micellular fluorogenic substrate for quantitating the activity of 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma (PLCγ) enzymes
Ramya Visvanathan, Tadanobu Utsuki, Daniel E. Beck, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0299541-e0299541
Open Access | Times Cited: 1
Investigating bleeding adverse events associated with BTK inhibitors in the food and drug administration adverse event reporting system (FAERS)
Xianlin Li, Nan Shang, Qianci Yan, et al.
Expert Opinion on Drug Safety (2024) Vol. 24, Iss. 2, pp. 183-192
Closed Access | Times Cited: 1
Characterization of a Novel Pathogenic PLCG2 Variant Leading to APLAID Syndrome Responsive to a TNF Inhibitor
Zhaohui Yang, Panfeng Tao, Xu Han, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 11, pp. 1670-1678
Closed Access | Times Cited: 1
PLCG2, A Regulator of Lung Adenocarcinoma Proliferation and Migration Associated with Immune Infiltration
Shuhui Chen, Chenkang Zhou, Jieying Dai, et al.
Current Cancer Drug Targets (2024) Vol. 25, Iss. 2, pp. 159-169
Closed Access | Times Cited: 1
In Silico Analysis of Non-Conventional Oxidative Stress-Related Enzymes and Their Potential Relationship with Carcinogenesis
Fábio Rodrigues Ferreira Seiva, Maria Luisa Gonçalves Agneis, Matheus Ribas de Almeida, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1279-1279
Open Access | Times Cited: 1
The PLCG2 Inhibits Tumor Progression and Mediates Angiogenesis by VEGF Signaling Pathway in Clear Cell Renal Cell Carcinoma
Chuanyi Zhao, Daojia Miao, Diaoyi Tan, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 11
Open Access | Times Cited: 1
Proteomics Analysis of Aqueous Humor and Rejected Graft in Pig-to-Non-Human Primate Corneal Xenotransplantation
Jae Won Oh, Chang Ho Yoon, Jin Suk Ryu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
The genetics behind inflammasome regulation
Suemy M. Yamada, Alessandra Pontillo
Molecular Immunology (2022) Vol. 145, pp. 27-42
Closed Access | Times Cited: 6
PLCγ2 impacts microglia-related effectors revealing variants and pathways important in Alzheimer’s disease
Ke Li, Beibei Ran, Yu Wang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 6
DCs- IL2 Necessary for Glucocorticoids Which Necessary for Interferons Synthesis and Serotonin Synthesis then Promote Ang2- At2 and VEGF-A for Anti-Inflammatory Growth
Ashraf Marzouk El Tantawi
Japan Journal of Clinical & Medical Research (2022), pp. 1-24
Open Access | Times Cited: 6
A novel fluorogenic reporter substrate for 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 (PLCγ2): Application to high-throughput screening for activators to treat Alzheimer's disease
Ramya Visvanathan, Tadanobu Utsuki, Daniel E. Beck, et al.
SLAS DISCOVERY (2023) Vol. 28, Iss. 4, pp. 170-179
Open Access | Times Cited: 3
Palmitoylation of the Alternative Amino Terminus of the BTK-C Isoform Controls Subcellular Distribution and Signaling
Mostafa Kokabee, Xianhui Wang, Elena Voorand, et al.
Cancer Genomics & Proteomics (2022) Vol. 19, Iss. 4, pp. 415-427
Open Access | Times Cited: 5
Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential
Tracey Immanuel, Jixia Li, Taryn N. Green, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Phospholipase Cγ2 Is Essential for Experimental Models of Epidermolysis Bullosa Acquisita
Kata P. Szilveszter, Simon Vikár, Ádám Horváth, et al.
Journal of Investigative Dermatology (2021) Vol. 142, Iss. 4, pp. 1114-1125
Open Access | Times Cited: 7
Editorial: Microglia and peripheral immune cells in aging and neurodegenerative diseases
Yiguo Qiu, Xianli Shen, Heping Xu
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 2
Aggressive progression to EGFR tyrosine kinase inhibitors in advanced NSCLC patients: concomitant mutations, prognostic indicator and subsequent management
Ruishan Wen, Ying Chen, Jinyu Long, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 8307-8316
Open Access | Times Cited: 2
A novel gain-of-function missense variant in PLCG2 associated with autoinflammation and hypergammaglobulinaemia
Takuji Itakura, Hirokazu Sasaki, Tadashi Hosoya, et al.
Lara D. Veeken (2023) Vol. 62, Iss. 11, pp. e319-e321
Closed Access | Times Cited: 2
Phospholipase C-γ as a Potential Therapeutic Target for Graves’ Orbitopathy
Tae Hoon Roh, Min Kyung Chae, JaeSang Ko, et al.
Endocrinology and Metabolism (2023) Vol. 38, Iss. 6, pp. 739-749
Open Access | Times Cited: 2


Acta Pediátrica de México (2023) Vol. 44, Iss. 6
Open Access | Times Cited: 2

Scroll to top